Skip to main content
Erschienen in: International Ophthalmology 1/2024

01.12.2024 | Review

Applications of photodynamic therapy in keratitis

verfasst von: Ayaz Anwar, Naveed Ahmed Khan, Ahmad M. Alharbi, Ayman Alhazmi, Ruqaiyyah Siddiqui

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Keratitis is corneal inflammatory disease which may be caused by several reason such as an injury, allergy, as well as a microbial infection. Besides these, overexposure to ultraviolet light and unhygienic practice of contact lenses are also associated with keratitis. Based on the cause of keratitis, different lines of treatments are recommended. Photodynamic therapy is a promising approach that utilizes light activated compounds to instigate either killing or healing mechanism to treat various diseases including both communicable and non-communicable diseases. This review focuses on clinically-important patent applications and the recent literature for the use of photodynamic therapy against keratitis.
Literatur
1.
Zurück zum Zitat Cope JR, Collier SA, Rao MM, Chalmers R, Mitchell GL, Richdale K, Wagner H, Kinoshita BT, Lam DY, Sorbara L, Zimmerman A (2015) Contact lens wearer demographics and risk behaviors for contact lens-related eye infections—United States, 2014. Morb Mortal Wkly Rep 64(32):865CrossRef Cope JR, Collier SA, Rao MM, Chalmers R, Mitchell GL, Richdale K, Wagner H, Kinoshita BT, Lam DY, Sorbara L, Zimmerman A (2015) Contact lens wearer demographics and risk behaviors for contact lens-related eye infections—United States, 2014. Morb Mortal Wkly Rep 64(32):865CrossRef
2.
Zurück zum Zitat Keay L, Edwards K, Stapleton F (2009) Signs, symptoms, and comorbidities in contact lens-related microbial keratitis. Optom Vis Sci 86(7):803–809CrossRefPubMed Keay L, Edwards K, Stapleton F (2009) Signs, symptoms, and comorbidities in contact lens-related microbial keratitis. Optom Vis Sci 86(7):803–809CrossRefPubMed
3.
Zurück zum Zitat Singh P, Gupta A, Tripathy K (2022) Keratitis. StatPearls Publishing, St. Petersburg Singh P, Gupta A, Tripathy K (2022) Keratitis. StatPearls Publishing, St. Petersburg
4.
Zurück zum Zitat Lakhundi S, Siddiqui R, Khan NA (2017) Pathogenesis of microbial keratitis. Microb Pathog 104:97–109CrossRefPubMed Lakhundi S, Siddiqui R, Khan NA (2017) Pathogenesis of microbial keratitis. Microb Pathog 104:97–109CrossRefPubMed
5.
Zurück zum Zitat Randag AC, de Kroon L, Otten H, Arias Claro-Handgraaf C, Schimmer B, Kortbeek T, van Rooij J, Stelma FF (2023) In vitro effectiveness of soft contact lens solutions available on the Dutch market against Acanthamoeba species. Pathogens 12(2):214CrossRefPubMedPubMedCentral Randag AC, de Kroon L, Otten H, Arias Claro-Handgraaf C, Schimmer B, Kortbeek T, van Rooij J, Stelma FF (2023) In vitro effectiveness of soft contact lens solutions available on the Dutch market against Acanthamoeba species. Pathogens 12(2):214CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Siddiqui R, Lakhundi S, Khan NA (2015) Status of the effectiveness of contact lens solutions against keratitis-causing pathogens. Cont Lens Anterior Eye 38(1):34–38CrossRefPubMed Siddiqui R, Lakhundi S, Khan NA (2015) Status of the effectiveness of contact lens solutions against keratitis-causing pathogens. Cont Lens Anterior Eye 38(1):34–38CrossRefPubMed
7.
Zurück zum Zitat Tjia KF, van Putten JP, Pels E, Zanen HC (1988) The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. An electron microscopic study. Graefes Arch Clin Exp Ophthalmol 226(4):341–345CrossRefPubMed Tjia KF, van Putten JP, Pels E, Zanen HC (1988) The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. An electron microscopic study. Graefes Arch Clin Exp Ophthalmol 226(4):341–345CrossRefPubMed
9.
Zurück zum Zitat Chatterjee S, Agrawal D (2016) Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate. Ind J Ophthalmol 64(2):153–157CrossRef Chatterjee S, Agrawal D (2016) Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate. Ind J Ophthalmol 64(2):153–157CrossRef
10.
Zurück zum Zitat Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ (2005) Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 3(3):419–434CrossRefPubMed Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ (2005) Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 3(3):419–434CrossRefPubMed
11.
Zurück zum Zitat Wilhelmus KR (2015) Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 1:CD002898PubMed Wilhelmus KR (2015) Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev 1:CD002898PubMed
12.
Zurück zum Zitat Khan NA, Anwar A, Siddiqui R (2019) Acanthamoeba keratitis: current status and urgent research priorities. Curr Med Chem 26(30):5711–5726CrossRefPubMed Khan NA, Anwar A, Siddiqui R (2019) Acanthamoeba keratitis: current status and urgent research priorities. Curr Med Chem 26(30):5711–5726CrossRefPubMed
13.
Zurück zum Zitat Green MD, Apel AJ, Naduvilath T, Stapleton FJ (2007) Clinical outcomes of keratitis. Clin Exp Ophthalmol 35(5):421–426CrossRefPubMed Green MD, Apel AJ, Naduvilath T, Stapleton FJ (2007) Clinical outcomes of keratitis. Clin Exp Ophthalmol 35(5):421–426CrossRefPubMed
14.
Zurück zum Zitat Austin A, Lietman T, Rose-Nussbaumer J (2017) Update on the management of infectious keratitis. Ophthalmology 124(11):1678–1689CrossRefPubMed Austin A, Lietman T, Rose-Nussbaumer J (2017) Update on the management of infectious keratitis. Ophthalmology 124(11):1678–1689CrossRefPubMed
15.
Zurück zum Zitat Tuft S, Somerville TF, Li JPO, Neal T, De S, Horsburgh MJ, Fothergill JL, Foulkes D, Kaye S (2022) Bacterial keratitis: identifying the areas of clinical uncertainty. Prog Retin Eye Res 89:101031CrossRefPubMed Tuft S, Somerville TF, Li JPO, Neal T, De S, Horsburgh MJ, Fothergill JL, Foulkes D, Kaye S (2022) Bacterial keratitis: identifying the areas of clinical uncertainty. Prog Retin Eye Res 89:101031CrossRefPubMed
16.
Zurück zum Zitat Daniell MD, Hill JS (1991) A history of photodynamic therapy. Aust N Z J Surg 61(5):340–348CrossRefPubMed Daniell MD, Hill JS (1991) A history of photodynamic therapy. Aust N Z J Surg 61(5):340–348CrossRefPubMed
17.
Zurück zum Zitat Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387CrossRefPubMed Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387CrossRefPubMed
18.
Zurück zum Zitat Correia JH, Rodrigues JA, Pimenta S, Dong T, Yang Z (2021) Photodynamic therapy review: principles, photosensitizers, applications, and future directions. Pharmaceutics 13(9):1332CrossRefPubMedPubMedCentral Correia JH, Rodrigues JA, Pimenta S, Dong T, Yang Z (2021) Photodynamic therapy review: principles, photosensitizers, applications, and future directions. Pharmaceutics 13(9):1332CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Nwogu C, Kloc A, Attwood K, Bshara W, Durrani F, Pandey R (2021) Porfimer sodium versus PS785 for photodynamic therapy (PDT) of lung cancer xenografts in mice. J Surg Res 263:245–250CrossRefPubMed Nwogu C, Kloc A, Attwood K, Bshara W, Durrani F, Pandey R (2021) Porfimer sodium versus PS785 for photodynamic therapy (PDT) of lung cancer xenografts in mice. J Surg Res 263:245–250CrossRefPubMed
21.
Zurück zum Zitat Kim M, Jung HY, Park HJ (2015) Topical PDT in the treatment of benign skin diseases: principles and new applications. Int J Mol Sci 16(10):23259–23278CrossRefPubMedPubMedCentral Kim M, Jung HY, Park HJ (2015) Topical PDT in the treatment of benign skin diseases: principles and new applications. Int J Mol Sci 16(10):23259–23278CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48(2):227–232CrossRefPubMed Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS (2003) Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48(2):227–232CrossRefPubMed
23.
Zurück zum Zitat Akram Z, Al-Shareef SA, Daood U, Asiri FY, Shah AH, AlQahtani MA, Vohra F, Javed F (2016) Bactericidal efficacy of photodynamic therapy against periodontal pathogens in periodontal disease: a systematic review. Photomed Laser Surg 34(4):137–149CrossRefPubMed Akram Z, Al-Shareef SA, Daood U, Asiri FY, Shah AH, AlQahtani MA, Vohra F, Javed F (2016) Bactericidal efficacy of photodynamic therapy against periodontal pathogens in periodontal disease: a systematic review. Photomed Laser Surg 34(4):137–149CrossRefPubMed
24.
Zurück zum Zitat Hung JH, Lee CN, Hsu HW, Ng IS, Wu CJ, Yu CK, Lee NY, Chang Y, Wong TW (2021) Recent advances in photodynamic therapy against fungal keratitis. Pharmaceutics 13(12):2011CrossRefPubMedPubMedCentral Hung JH, Lee CN, Hsu HW, Ng IS, Wu CJ, Yu CK, Lee NY, Chang Y, Wong TW (2021) Recent advances in photodynamic therapy against fungal keratitis. Pharmaceutics 13(12):2011CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat de Paiva AD, da Costa Ferreira M, da Fonseca AD (2022) Photodynamic therapy for treatment of bacterial keratitis. Photodiagnosis Photodyn Ther 37:102717CrossRefPubMed de Paiva AD, da Costa Ferreira M, da Fonseca AD (2022) Photodynamic therapy for treatment of bacterial keratitis. Photodiagnosis Photodyn Ther 37:102717CrossRefPubMed
26.
Zurück zum Zitat Szentmáry N, Goebels S, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109:165–170CrossRefPubMed Szentmáry N, Goebels S, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109:165–170CrossRefPubMed
27.
Zurück zum Zitat Han H, Gao Y, Chai M, Zhang X, Liu S, Huang Y, Jin Q, Grzybowski A, Ji J, Yao K (2020) Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis. J Control Rel 327:676–687CrossRef Han H, Gao Y, Chai M, Zhang X, Liu S, Huang Y, Jin Q, Grzybowski A, Ji J, Yao K (2020) Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis. J Control Rel 327:676–687CrossRef
28.
Zurück zum Zitat Bai Y, Hu Y, Gao Y, Wei X, Li J, Zhang Y, Wu Z, Zhang X (2021) Oxygen self-supplying nanotherapeutic for mitigation of tissue hypoxia and enhanced photodynamic therapy of bacterial keratitis. ACS Appl Mater Interfaces 13(29):33790–33801CrossRefPubMed Bai Y, Hu Y, Gao Y, Wei X, Li J, Zhang Y, Wu Z, Zhang X (2021) Oxygen self-supplying nanotherapeutic for mitigation of tissue hypoxia and enhanced photodynamic therapy of bacterial keratitis. ACS Appl Mater Interfaces 13(29):33790–33801CrossRefPubMed
29.
Zurück zum Zitat Su G, Wei Z, Wang L, Shen J, Baudouin C, Labbé A, Liang Q (2020) Evaluation of toluidine blue-mediated photodynamic therapy for experimental bacterial keratitis in rabbits. Transl Vision Sci Technol 9(3):13CrossRef Su G, Wei Z, Wang L, Shen J, Baudouin C, Labbé A, Liang Q (2020) Evaluation of toluidine blue-mediated photodynamic therapy for experimental bacterial keratitis in rabbits. Transl Vision Sci Technol 9(3):13CrossRef
30.
Zurück zum Zitat Arboleda A, Miller D, Cabot F, Taneja M, Aguilar MC, Alawa K, Amescua G, Yoo SH, Parel JM (2014) Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Amer J Ophthalmol 158(1):64–70CrossRefPubMed Arboleda A, Miller D, Cabot F, Taneja M, Aguilar MC, Alawa K, Amescua G, Yoo SH, Parel JM (2014) Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Amer J Ophthalmol 158(1):64–70CrossRefPubMed
31.
Zurück zum Zitat Shih MH, Huang FC (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223–229CrossRefPubMed Shih MH, Huang FC (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223–229CrossRefPubMed
32.
Zurück zum Zitat Aqeel Y, Siddiqui R, Anwar A, Shah MR, Khoja S, Khan NA (2015) Photochemotherapeutic strategy against Acanthamoeba infections. Antimicrob Agents Chemother 59(6):3031–3041CrossRefPubMedPubMedCentral Aqeel Y, Siddiqui R, Anwar A, Shah MR, Khoja S, Khan NA (2015) Photochemotherapeutic strategy against Acanthamoeba infections. Antimicrob Agents Chemother 59(6):3031–3041CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Imran M, Muazzam AG, Habib A, Matin A (2016) Synthesis, characterization and amoebicidal potential of locally synthesized TiO2 nanoparticles against pathogenic Acanthamoeba trophozoites in vitro. J Photochem Photobiol B Biol 159:125–132CrossRef Imran M, Muazzam AG, Habib A, Matin A (2016) Synthesis, characterization and amoebicidal potential of locally synthesized TiO2 nanoparticles against pathogenic Acanthamoeba trophozoites in vitro. J Photochem Photobiol B Biol 159:125–132CrossRef
34.
Zurück zum Zitat Gomart G, Denis J, Bourcier T, Dory A, Abou-Bacar A, Candolfi E, Sauer A (2018) In vitro amoebicidal activity of titanium dioxide/UV-A combination against Acanthamoeba. Invest Ophthalmol Vis Sci 59(11):4567–4571CrossRefPubMed Gomart G, Denis J, Bourcier T, Dory A, Abou-Bacar A, Candolfi E, Sauer A (2018) In vitro amoebicidal activity of titanium dioxide/UV-A combination against Acanthamoeba. Invest Ophthalmol Vis Sci 59(11):4567–4571CrossRefPubMed
35.
Zurück zum Zitat Dwia Pertiwi Y, Chikama T, Sueoka K, Ko JA, Kiuchi Y, Onodera M, Sakaguchi T (2021) Efficacy of photodynamic anti-microbial chemotherapy for Acanthamoeba keratitis in vivo. Lasers Surg Med 53(5):695–702CrossRefPubMed Dwia Pertiwi Y, Chikama T, Sueoka K, Ko JA, Kiuchi Y, Onodera M, Sakaguchi T (2021) Efficacy of photodynamic anti-microbial chemotherapy for Acanthamoeba keratitis in vivo. Lasers Surg Med 53(5):695–702CrossRefPubMed
36.
Zurück zum Zitat Pertiwi YD, Chikama T, Sueoka K, Ko JA, Kiuchi Y, Onodera M, Sakaguchi T (2019) Antimicrobial photodynamic therapy with the photosensitizer TONS504 eradicates Acanthamoeba. Photodiagnosis Photodyn Ther 28:166–171CrossRefPubMed Pertiwi YD, Chikama T, Sueoka K, Ko JA, Kiuchi Y, Onodera M, Sakaguchi T (2019) Antimicrobial photodynamic therapy with the photosensitizer TONS504 eradicates Acanthamoeba. Photodiagnosis Photodyn Ther 28:166–171CrossRefPubMed
37.
Zurück zum Zitat Atalay HT, Uysal BS, Sarzhanov F, Usluca S, Yeşilırmak N, Özmen MC, Erganiş S, Tefon AB, Dogruman-Al F, Bilgihan K (2020) Rose Bengal-mediated photodynamic antimicrobial treatment of Acanthamoeba keratitis. Curr Eye Res 45(10):1205–1210CrossRefPubMed Atalay HT, Uysal BS, Sarzhanov F, Usluca S, Yeşilırmak N, Özmen MC, Erganiş S, Tefon AB, Dogruman-Al F, Bilgihan K (2020) Rose Bengal-mediated photodynamic antimicrobial treatment of Acanthamoeba keratitis. Curr Eye Res 45(10):1205–1210CrossRefPubMed
38.
Zurück zum Zitat Chen Z, Xuguang S, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Brit J Ophthalmol 92(9):1283–1286CrossRef Chen Z, Xuguang S, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Brit J Ophthalmol 92(9):1283–1286CrossRef
39.
Zurück zum Zitat Mito T, Suzuki T, Kobayashi T, Zheng X, Hayashi Y, Shiraishi A, Ohashi Y (2012) Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro. Invest Ophthalmol Vis Sci 53(10):6305–6313CrossRefPubMed Mito T, Suzuki T, Kobayashi T, Zheng X, Hayashi Y, Shiraishi A, Ohashi Y (2012) Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro. Invest Ophthalmol Vis Sci 53(10):6305–6313CrossRefPubMed
40.
Zurück zum Zitat Korea Institute of Science and Technology: KR20220158663A (2022). Korea Institute of Science and Technology: KR20220158663A (2022).
41.
42.
Zurück zum Zitat Hangzhou Dac Biotech Co Ltd: AU2022206809A1 (2022). Hangzhou Dac Biotech Co Ltd: AU2022206809A1 (2022).
43.
Zurück zum Zitat Aldeyra Therapeutics, Inc.: WO2023278816A1 (2023). Aldeyra Therapeutics, Inc.: WO2023278816A1 (2023).
44.
Zurück zum Zitat Wenzhou Medical University: CN114907573A (2022). Wenzhou Medical University: CN114907573A (2022).
45.
Zurück zum Zitat Eye and ENT Hospital of Fudan University: CN115054432A (2022). Eye and ENT Hospital of Fudan University: CN115054432A (2022).
46.
Zurück zum Zitat Wenzhou Medical University: CN114942530A (2022). Wenzhou Medical University: CN114942530A (2022).
47.
Zurück zum Zitat Wenzhou Medical University: CN114588524A (2022). Wenzhou Medical University: CN114588524A (2022).
48.
Zurück zum Zitat Allysta Pharmaceuticals Inc.: US20220331393A1 (2022). Allysta Pharmaceuticals Inc.: US20220331393A1 (2022).
49.
Zurück zum Zitat Desmond Christopher Adler, Jason Hill, David Usher, Mikhail Smirnov, Ahalya Viswanathan: US20220193439A1 (2021). Desmond Christopher Adler, Jason Hill, David Usher, Mikhail Smirnov, Ahalya Viswanathan: US20220193439A1 (2021).
50.
51.
Zurück zum Zitat Ushio Denki KK: US20220062473A1 (2022). Ushio Denki KK: US20220062473A1 (2022).
52.
Zurück zum Zitat Nisshang Santen Pharmaceutical Co., Ltd., Nisshang Phibotek Medical Equipment Co., Ltd.: TW202216153A (2022). Nisshang Santen Pharmaceutical Co., Ltd., Nisshang Phibotek Medical Equipment Co., Ltd.: TW202216153A (2022).
53.
Zurück zum Zitat Korea Advanced Institute of Science and Technology KAIST: US20210393723A1 (2021). Korea Advanced Institute of Science and Technology KAIST: US20210393723A1 (2021).
54.
Zurück zum Zitat University Of Miami: WO2021237131A1 (2021). University Of Miami: WO2021237131A1 (2021).
55.
Zurück zum Zitat University Of Miami: WO2021202398A1 (2021). University Of Miami: WO2021202398A1 (2021).
56.
Zurück zum Zitat Wenzhou Research Institute Of Chinese Academy Of Sciences, Wenzhou Institute Of Biomaterials And Engineering: CN113041348A (2021). Wenzhou Research Institute Of Chinese Academy Of Sciences, Wenzhou Institute Of Biomaterials And Engineering: CN113041348A (2021).
57.
Zurück zum Zitat Qingdao University: CN112891535A (2021). Qingdao University: CN112891535A (2021).
58.
Zurück zum Zitat Qingdao University: CN112915204A (2021). Qingdao University: CN112915204A (2021).
59.
60.
Zurück zum Zitat Universidade De São Paulo – Usp: BR102020025170A2 (2021). Universidade De São Paulo – Usp: BR102020025170A2 (2021).
61.
62.
Zurück zum Zitat Vision Engineering Italy Srl: WO2021009623A1 (2020). Vision Engineering Italy Srl: WO2021009623A1 (2020).
63.
Zurück zum Zitat The University of Massachusetts, The General Hospital Corporation: WO2020251933A1 (2020). The University of Massachusetts, The General Hospital Corporation: WO2020251933A1 (2020).
64.
Zurück zum Zitat Harbin Normal University: CN111467490A (2020). Harbin Normal University: CN111467490A (2020).
65.
Zurück zum Zitat Korea Institute of Science and Technology: KR20210093608A (2022). Korea Institute of Science and Technology: KR20210093608A (2022).
66.
Zurück zum Zitat University of California, US Department of Veterans Affairs VA: JP2022503941A (2022) University of California, US Department of Veterans Affairs VA: JP2022503941A (2022)
67.
Zurück zum Zitat California Institute Of Technology: WO2020061079A1 (2020) California Institute Of Technology: WO2020061079A1 (2020)
68.
Zurück zum Zitat Seoul Viosys Co., Ltd.: WO2019209063A1 (2019) Seoul Viosys Co., Ltd.: WO2019209063A1 (2019)
69.
Zurück zum Zitat Aleyegn Technologies LLC: US20200000638A1 (2020) Aleyegn Technologies LLC: US20200000638A1 (2020)
70.
Zurück zum Zitat Garg P, Das S, Roy A (2017) Collagen cross-linking for microbial keratitis. Middle East Afr J Ophthalmol 24(1):18PubMedPubMedCentral Garg P, Das S, Roy A (2017) Collagen cross-linking for microbial keratitis. Middle East Afr J Ophthalmol 24(1):18PubMedPubMedCentral
Metadaten
Titel
Applications of photodynamic therapy in keratitis
verfasst von
Ayaz Anwar
Naveed Ahmed Khan
Ahmad M. Alharbi
Ayman Alhazmi
Ruqaiyyah Siddiqui
Publikationsdatum
01.12.2024
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-024-03062-4

Weitere Artikel der Ausgabe 1/2024

International Ophthalmology 1/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.